Fig. 1From: Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisoneKaplan-Meier survival curves of PFS (A: PSA50; C: PSA30) and OS (B: PSA50; D: PSA30) stratified by PSA response to A + D treatment. PFS: progression-free survival; OS: overall survivalBack to article page